Claims for Patent: 10,227,328
✉ Email this page to a colleague
Summary for Patent: 10,227,328
Title: | Heterocyclic compound and pharmaceutical composition comprising same |
Abstract: | The present invention relates to a novel heterocyclic compound inhibiting a cyclin-dependent kinase (CDK) and a pharmaceutical composition comprising the same as an effective ingredient. The heterocyclic compound according to the present invention or pharmaceutically acceptable salt thereof can be effectively used in treating or preventing cancers, degenerative brain diseases, etc. |
Inventor(s): | Min; Changhee (Daejeon, KR), Oh; Byungkyu (Gyeryong-si, KR), Kim; Yongeun (Daejeon, KR), Park; Changmin (Daejeon, KR) |
Assignee: | BEYONDBIO INC. (Daejeon, KR) |
Application Number: | 15/546,714 |
Patent Claims: | 1. A compound of formula (I) or pharmaceutically acceptable salt thereof: ##STR00148## wherein, X is nitrogen, Y and Z are carbon; R.sub.1 is phenyl, pyridine, or
pyrimidine substituted or unsubstituted with one or more substituents selected from the group consisting of hydroxy, amino, and halogen; R.sub.2 is hydrogen; and R.sub.3 is pyrimidine substituted or unsubstituted with one or more substituents selected
from the group consisting of C.sub.1-C.sub.6 alkyl, tetrahydropyranyl, piperidinyl substituted or unsubstituted with C.sub.1-C.sub.6 alkyl, morpholino, piperazinyl substituted or unsubstituted with C.sub.1-C.sub.6 alkyl, amino, C.sub.1-C.sub.6
alkylamino, and halogen.
2. The compound according to claim 1 or pharmaceutically acceptable salt thereof selected from the group consisting of the following compounds: 2,6-bis(2-aminopyrimidin-4-yl)pyridin-3-ol; 2'-amino-6-(2-aminopyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]-5-ol; 2-(2-aminopyrimidin-4-yl)-6-(4-hydroxyphenyl)pyridin-3-ol; 2'-amino-6-(2-aminopyrimidin-4-yl)-[2,4'-bipyridin]-5-ol; 6-(2-aminopyrimidin-4-yl)-[2,3'-bipyridin]-5-ol; 6-(2-aminopyrimidin-4-yl)-[2,4'-bipyridin]-5-ol; 2-(2-aminopyrimidin-4-yl)-6-(3-hydroxyphenyl)pyridin-3-ol; 6-(2-aminopyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]-5-ol; 6-(4-amino-2-fluorophenyl)-2-(2-aminopyrimidin-4-yl)pyridin-3-ol; 6-(3-aminophenyl)-2-(2-aminopyrimidin-4-yl)pyridin-3-ol; 2-(2-aminopyrimidin-4-yl)-6-(2-fluoro-4-hydroxyphenyl)pyridin-3-ol; 6-(3-amino-2-fluorophenyl)-2-(2-aminopyrimidin-4-yl)pyridin-3-ol; 2-(2-aminopyrimidin-4-yl)-6-(3-fluoro-4-hydroxyphenyl)pyridin-3-ol; 2-(2-aminopyrimidin-4-yl)-6-(2,3-difluoro-4-hydroxyphenyl)pyridin-3-ol; 2'-amino-6-(2-aminopyrimidin-4-yl)-[2,4'-bipyridin]-3',5-diol; 2'-amino-6-(2-amino-6-methylpyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]-5-- ol; 6-(2-amino-6-methylpyrimidin-4-yl)-[2,4'-bipyridin]-5-ol; 6-(2-amino-6-methylpyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]-5-ol; 2-(2-amino-6-methylpyrimidin-4-yl)-6-(4-hydroxyphenyl)pyridin-3-ol; 2-(2-amino-6-methylpyrimidin-4-yl)-6-(2,3-difluoro-4-hydroxyphenyl)pyridi- n-3-ol; 2-(2-amino-6-methylpyrimidin-4-yl)-6-(2-fluoro-4-hydroxyphenyl)pyr- idin-3-ol; 2-(2-amino-6-methylpyrimidin-4-yl)-6-(3-aminophenyl)pyridin-3-o- l; 2'-amino-6-(2-amino-6-isopropylpyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridi- n]-5-ol; 2'-amino-6-(2-amino-6-(tetrahydro-2H-pyran-4-yl)pyrimidin-4-yl)-3- '-fluoro-[2,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-6-(piperidin-4-yl)pyrimidin-4-yl)-3'-fluoro-[2,4'-bip- yridin]-5-ol; 2'-amino-6-(2-amino-6-(1-methylpiperidin-4-yl)pyrimidin-4-yl)-3'-fluoro-[- 2,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-6-(1-ethylpiperidin-4-yl)pyrimidin-4-yl)-3'-fluoro-[2- ,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-6-(1-propylpiperidin-4-yl)pyrimidin-4-yl)-3'-fluoro-[- 2,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-6-(1-isopropylpiperidin-4-yl)pyrimidin-4-yl)-3'-fluor- o-[2,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-6-(1-methylpiperidin-3-yl)pyrimidin-4-yl)-3'-fluoro-[- 2,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-6-(1-ethylpiperidin-3-yl)pyrimidin-4-yl)-3'-fluoro-[2- ,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-6-(1-propylpiperidin-3-yl)pyrimidin-4-yl)-3'-fluoro-[- 2,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-6-(1-isopropylpiperidin-3-yl)pyrimidin-4-yl)-3'-fluor- o-[2,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-5-methyl-6-(1-methylpiperidin-4-yl)pyrimidin-4-yl)-3'- -fluoro-[2,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-6-(1-ethylpiperidin-4-yl)-5-methylpyrimidin-4-yl)-3'-- fluoro-[2,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-5-methyl-6-(1-propylpiperidin-4-yl)pyrimidin-4-yl)-3'- -fluoro-[2,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-6-(1-isopropylpiperidin-4-yl)-5-methylpyrimidin-4-yl)- -3'-fluoro-[2,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-5-methyl-6-(1-methylpiperidin-3-yl)pyrimidin-3-yl)-3'- -fluoro-[2,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-5-methyl-6-(1-propylpiperidin-3-yl)pyrimidin-4-yl)-3'- -fluoro-[2,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-6-(1-isopropylpiperidin-3-yl)-5-methylpyrimidin-4-yl)- -3'-fluoro-[2,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-5-ethyl-6-(1-isopropylpiperidin-4-yl)pyrimidin-4-yl)-- 3'-fluoro-[2,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-6-(1-isopropylpiperidin-4-yl)-5-propylpyrimidin-4-yl)- -3'-fluoro-[2,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-6-morpholinopyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin- ]-5-ol; 2'-amino-6-(2-amino-6-(dimethylamino)pyrimidin-4-yl)-3'-fluoro-[2,- 4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)-3'-fluoro-[- 2,4'-bipyridin]-5-ol; 6-(2-amino-6-chloropyrimidin-4-yl)-[2,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-5-methylpyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]-5-- ol; 2'-amino-6-(2-amino-5-ethylpyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]-- 5-ol; 2'-amino-6-(2-amino-5-propylpyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridi- n]-5-ol; 2'-amino-6-(2-amino-5-isopropylpyrimidin-5-yl)-3'-fluoro-[2,4'-bi- pyridin]-5-ol; 2'-amino-3'-fluoro-6-(2-(methylamino)-6-(1-methylpiperidin-4-yl)pyrimidin- -4-yl)-[2,4'-bipyridin]-5-ol; 2'-amino-6-(2-amino-5,6-dimethylpyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin- ]-5-ol; 2,6-bis(2-aminopyrimidin-4-yl)pyridin-3-ol 3hydrochloride; 2,6-bis(2-aminopyrimidin-4-yl)pyridin-3-ol oxalate; 2,6-bis(2-aminopyrimidin-4-yl)pyridin-3-ol malonate; 2,6-bis(2-aminopyrimidin-4-yl)pyridin-3-ol sulfate; 2'-amino-4-(2-aminopyrimidin-4-yl)-[2,4'-bipyridin]-5-ol oxalate; 2'-amino-6-(2-aminopyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]-5-ol 3hydrochloride; 2'-amino-6-(2-aminopyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]-5-ol acetate; 2'-amino-6-(2-aminopyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]-5-- ol oxalate; 2'-amino-6-(2-aminopyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]-5-ol 2malonate; 2-(2-aminopyrimidin-4-yl)-6-(2-fluoro-4-hydroxyphenyl)pyridin-3-ol 2hydrochloride; 2'-amino-6-(2-amino-6-methylpyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]-5-- ol 3hydrochloride; 2'-amino-6-(2-amino-6-morpholinopyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin- ]-5-ol 4hydrochloride; 2'-amino-6-(2-amino-6-morpholinopyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin- ]-5-ol acetate; 2'-amino-6-(2-amino-6-(dimethylamino)pyrimidin-4-yl)-3'-fluoro-[2,4'-bipy- ridin]-5-ol 4hydrochloride; 2'-amino-6-(2-amino-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)-3'-fluoro-[- 2,4'-bipyridin]-5-ol 5hydrochloride; 2'-amino-6-(2-amino-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)-3'-fluoro-[- 2,4'-bipyridin]-5-ol acetate; 2'-amino-6-(2-amino-(6-(1-methylpiperidin-4-yl)pyrimidin-4-yl)-3'-fluoro-- [2,4'-bipyridin]-5-ol 4hydrochloride; 2'-amino-6-(2-amino-6-(1-methylpiperidin-4-yl)pyrimidin-4-yl)-3'-fluoro-[- 2,4'-bipyridin]-5-ol 2acetate; 2'-amino-6-(2-amino-6-(1-methylpiperidin-4-yl)pyrimidin-4-yl)-3'-fluoro-[- 2,4'-bipyridin]-5-ol oxalate; 2'-amino-6-(2-amino-6-(1-methylpiperidin-4-yl)pyrimidin-4-yl)-3'-fluoro-[- 2,4'-bipyridin]-5-ol malonate; 2'-amino-6-(2-amino-6-isopropylpyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]- -5-ol 3hydrochloride; 2'-amino-6-(2-amino-6-isopropylpyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]- -5-ol 2acetate; 2'-amino-6-(2-amino-6-(piperidin-4-yl)pyrimidin-4-yl)-3'-fluoro-[2,4'-bip- yridin]-5-ol 4hydrochloride; 2'-amino-6-(2-amino-6-(piperidin-4-yl)pyrimidin-4-yl)-3'-fluoro-[2,4'-bip- yridin]-5-ol acetate; 2'-amino-6-(2-amino-6-(tetrahydro-2H-pyran-4-yl)pyrimidin-4-yl)-3'-fluoro- -[2,4'-bipyridin]-5-ol 3hydrochloride; 2'-amino-6-(2-amino-6-(1-ethylpiperidin-4-yl)pyrimidin-4-yl)-3'-fluoro-[2- ,4'-bipyridin]-5-ol 4hydrochloride; 2'-amino-6-(2-amino-6-(1-propylpiperidin-4-yl)pyrimidin-4-yl)-3'-fluoro-[- 2,4'-bipyridin]-5-ol 4hydrochloride; 2'-amino-6-(2-amino-6-(1-isopropylpiperidin-4-yl)pyrimidin-4-yl)-3'-fluor- o-[2,4'-bipyridin]-5-ol 4hydrochloride; 2'-amino-6-(2-amino-6-(1-methylpiperidin-3-yl)pyrimidin-4-yl)-3'-fluoro-[- 2,4'-bipyridin]-5-ol 4hydrochloride; 2'-amino-6-(2-amino-6-(1-ethylpiperidin-3-yl)pyrimidin-4-yl)-3'-fluoro-[2- ,4'-bipyridin]-5-ol 4hydrochloride; 2'-amino-6-(2-amino-6-(1-propylpiperidin-3-yl)pyrimidin-4-yl)-3'-fluoro-[- 2,4'-bipyridin]-5-ol 4hydrochloride; 2'-amino-6-(2-amino-6-(1-isopropylpiperidin-3-yl)pyrimidin-4-yl)-3'-fluor- o[2,4'-bipyridin]-5-ol 4hydrochloride; 2'-amino-6-(2-amino-5-methyl-6-(1-methylpiperidin-4-yl)pyrimidin-4-yl)-3'- -fluoro-[2,4'-bipyridin]-5-ol 4hydrochloride; 2'-amino-6-(2-amino-6-(1-ethylpiperidin-4-yl)-5-methylpyrimidin-4-yl)-3'-- fluoro-[2,4'-bipyridin]-5-ol 4hydrochloride; 2'-amino-6-(2-amino-5-methyl-6-(1-propylpiperidin-4-yl)pyrimidin-4-yl)-3'- -fluoro-[2,4'-bipyridin]-5-ol 4hydrochloride; 2'-amino-6-(2-amino-6-(1-isopropylpiperidin-4-yl)-5-methylpyrimidin-4-yl)- -3'-fluoro-[2,4'-bipyridin]-5-ol 4hydrochloride; 2'-amino-6-(2-amino-5-methyl-6-(1-methylpiperidin-3-yl)pyrimidin-3-yl)-3'- -fluoro-[2,4'-bipyridin]-5-ol 4hydrochloride; 2'-amino-6-(2-amino-5-methyl-6-(1-propylpiperidin-3-yl)pyrimidin-4-yl)-3'- -fluoro-[2,4'-bipyridin]-5-ol 4hydrochloride; 2'-amino-6-(2-amino-6-(1-isopropylpiperidin-3-yl)-5-methylpyrimidin-4-yl)- -3'-fluoro-[2,4'-bipyridin]-5-ol 4hydrochloride; 2'-amino-6-(2-amino-5-methylpyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]-5-- ol 3hydrochloride; 2'-amino-6-(2-amino-5,6-dimethylpyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin- ]-5-ol 3hydrochloride; 2'-amino-6-(2-amino-5-ethylpyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]-5-o- l 3hydrochloride; 2'-amino-6-(2-amino-5-propylpyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]-5-- ol 3hydrochloride; 2'-amino-6-(2-amino-5-isopropylpyrimidin-5-yl)-3'-fluoro-[2,4'-bipyridin]- -5-ol 3hydrochloride; 2'-amino-6-(2-amino-5-ethyl-6-(1-isopropylpiperidin-4-yl)pyrimidin-4-yl)-- 3'-fluoro-[2,4'-bipyridin]-5-ol 4hydrochloride; and 2'-amino-6-(2-amino-6-(1-isopropylpiperidin-4-yl)-5-propylpyrimidin-4-yl)- -3'-fluoro-[2,4'-bipyridin]-5-ol 4hydrochloride. 3. A pharmaceutical composition comprising the compound according to claim 1 or pharmaceutically acceptable salt thereof together with a pharmaceutically acceptable carrier. 4. The pharmaceutical composition according to claim 3, wherein the compound of formula (I) or pharmaceutically acceptable salt thereof is administered in combination with one or more anticancer agents selected from the group consisting of capecitabine, 5-fluorouracil, thioguanine, chlorambucil, oxaliplatin, cisplatin, carboplatin, paclitaxel, docetaxel, irinotecan, doxorubicin, vinorelbin, gemcitabine, pemetrexed, etoposide, vincristine, citarabine, cyclophosphamide, iphosphamide, tamoxifen, anastrozole, retrozole, exemestane, fulvestrant, temozolomide, camustine, lomustine, epirubicine, eribulin, toremifene, goserelin, megestrol, vinblastine, bendamustine, thiotepa, bleomycin, topotecan, leucovorin, trifluridine, tipiracil, mitomycin C, aldesleukin, temsirolimus, everolimus, mitoxantrone, mecloretamine, methotrexate, trastuzumab, bevacizumab, cetuximab, aflibercept, pertuzumab, ramucirumab, panitumumab, nivolumab, necitumumab, pembrolizumab, obinutuzumab, ofatumumab, erlotinib, gefitinib, sorafenib, lapatinib, palbociclib, regorafenib, imatinib, sunitinib, axitinib, pazopanib, apatinib, ceritinib, crizotinib, osimertinib, bosutinib, dasatinib, nilotinib, ponatinib, hydroxyurea, and procarbazine. 5. The pharmaceutical composition according to claim 3, wherein the compound of formula (I) or pharmaceutically acceptable salt thereof is administered in combination with one or more drugs for treating a degenerative brain disease selected from the group consisting of levodopa, bromocriptine, ropinirole, pramipexole, rotigotine, trihexyphenidyl, benztropine, procyclidine, entacapone, selegiline, rasagiline, amantadine, tetrabenazine, donepezil, rivastigmine, galantamine and memantine. 6. The pharmaceutical composition according to claim 3, wherein the compound of formula (I) or pharmaceutically acceptable salt thereof is administered in combination with temozolomide. 7. A method for treating Alzheimer disease in a subject in need thereof, comprising administering a composition comprising the compound of formula (I) or pharmaceutically acceptable salt thereof according to claim 1 to the subject. 8. A method for inhibiting a cyclin dependent kinase (CDK) in a subject, comprising administering a composition comprising the compound of formula (I) or pharmaceutically acceptable salt thereof according to claim 1 to the subject. 9. A method for treating cancer in a subject in need thereof, comprising administering an effective amount of a composition comprising the compound of formula (I) or pharmaceutically acceptable salt thereof according to claim 1 to the subject, wherein said cancer is selected from the group consisting of colon cancer, lung cancer, glioma, and brain cancer. 10. The method according to claim 9, which further comprises administering one or more anticancer agents selected from the group consisting of capecitabine, 5-fluorouracil, thioguanine, chlorambucil, oxaliplatin, cisplatin, carboplatin, paclitaxel, docetaxel, irinotecan, doxorubicin, vinorelbin, gemcitabine, pemetrexed, etoposide, vincristine, citarabine, cyclophosphamide, iphosphamide, tamoxifen, anastrozole, retrozole, exemestane, fulvestrant, temozolomide, camustine, lomustine, epirubicine, eribulin, toremifene, goserelin, megestrol, vinblastine, bendamustine, thiotepa, bleomycin, topotecan, leucovorin, trifluridine, tipiracil, mitomycin C, aldesleukin, temsirolimus, everolimus, mitoxantrone, mecloretamine, methotrexate, trastuzumab, bevacizumab, cetuximab, aflibercept, pertuzumab, ramucirumab, panitumumab, nivolumab, necitumumab, pembrolizumab, obinutuzumab, ofatumumab, erlotinib, gefitinib, sorafenib, lapatinib, palbociclib, regorafenib, imatinib, sunitinib, axitinib, pazopanib, apatinib, ceritinib, crizotinib, osimertinib, bosutinib, dasatinib, nilotinib, ponatinib, hydroxyurea, and procarbazine. 11. The method according to claim 9, which further comprises administering temozolomide. 12. The method according to claim 6, which further comprises administering one or more drugs selected from the group consisting of levodopa, bromocriptine, ropinirole, pramipexole, rotigotine, trihexyphenidyl, benztropine, procyclidine, entacapone, selegiline, rasagiline, amantadine, tetrabenazine, donepezil, rivastigmine, galantamine and memantine. |
Details for Patent 10,227,328
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Clinigen, Inc. | PROLEUKIN | aldesleukin | For Injection | 103293 | 05/05/1992 | ⤷ Try a Trial | 2035-02-04 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2035-02-04 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2035-02-04 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.